Far Infrared Radiation Treatment for Uterine Fibroids

Status Active, not recruiting

Clinical Trial Summary

A preliminary study to determine the efficacy of using energy specific far infrared (FIR) radiation for the treatment of uterine fibroids.

Clinical Trial Description

Uterine fibroids are the most common neoplasms of the female pelvis. These benign tumors are generally oval in shape and often highly vascular. On MR imaging exams, uterine fibroids are easily identifiable. They occur in 20-25% of women of reproductive age and can cause a variety of problems generally described as either bleeding or mass effects from the fibroid.

We are postulating that energy specific electromagnetic radiation of the uterus will shrink the benign tumors. ;

Study Design

Allocation: Non-Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment

Related Conditions & MeSH terms

Leiomyoma

Clinical Trial Details

NCT number	NCT00574418
Study type	Interventional
Source	GAAD Medical Research Institute Inc.
Contact
Status	Active, not recruiting
Phase	Phase 1
Start date	January 2006
Completion date	September 2008

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT04172272` - The Influence of TAP Block in the Control of Postoperative Pain After Laparotomy for Gynecological Procedures	N/A
Terminated	`NCT02940041` - Concordance Between Sonography Amd MRI for Presurgical Diagnosis of Uterine Mesenchymal Malignant Tumors
Withdrawn	`NCT00768742` - Safety and Effectiveness Study of RF Ablation of Uterine Fibroids to Reduce Menstrual Bleeding: the Fibroid Ablation Study	N/A
Completed	`NCT00156195` - Study to Evaluate the Safety of Asoprisnil in the Treatment of Uterine Fibroids	Phase 3
Completed	`NCT00152256` - A Study to Evaluate of the Safety and Effectiveness of Asoprisnil in Treating Women With Uterine Fibroids	Phase 3
Completed	`NCT00160381` - A Study to Evaluate the Safety and Effectiveness of Asoprisnil in the Treatment of Uterine Fibroids	Phase 3
Recruiting	`NCT04214457` - Development of a Predictive Model for Early Differential Diagnosis of Uterine Leiomyomas and Leiomyosarcomas
Completed	`NCT00044876` - Treatment of Uterine Fibroids With CDB-2914, an Experimental Selective Progesterone Receptor Antagonist	Phase 2
Completed	`NCT02889848` - Safety and Tolerability of Collagenase Clostridium Histolyticum (EN3835) to Treat Uterine Leiomyoma (Fibroids)	Phase 1
Recruiting	`NCT04145518` - Mechanistic Characterization of Uterine Pain	Phase 4
Completed	`NCT01816815` - Study in Healthy Tubal Ligated Women to Evaluate Pharmacodynamics, Safety and Pharmacokinetics of BAY1002670	Phase 1
Completed	`NCT00891657` - Post Market Study for an Adhesion Barrier Following Laparoscopic Myomectomy	N/A
Completed	`NCT00156156` - Study of Asoprisnil in the Treatment of Uterine Fibroids.	Phase 3
Recruiting	`NCT05538689` - Surgical Myomectomy Followed by Oral Myfembree Versus Standard of Care Trial (SOUL)	Phase 4
Active, not recruiting	`NCT03323905` - Single Arm Study Using the Symphony -- MRI Guided Focused Ultrasound System for the Treatment of Leiomyomas	N/A
Terminated	`NCT03342859` - Mode of Action Study of Vilaprisan and Ulipristal Acetate in Patients With Uterine Fibroids for Whom Surgery is Planned	Phase 1
Recruiting	`NCT06135870` - Role of Senescent Cells in Uterine Fibroid Pathogenesis (SOUL Study)
Completed	`NCT02777203` - Power Morcellation Systems for Laparoscopic Hysterectomy and Myomectomy	N/A
Completed	`NCT02189083` - Study of Tumor-shrinking Decoction (TSD) to Treat Symptomatic Uterine Fibroids	Phase 3
Completed	`NCT01123603` - Lower Urinary Tract Infection (UTI) Evaluation in Women With Uterine Leiomyomata	N/A